Suramin induced ceramide accumulation leads to apoptotic cell death in dorsal root ganglion neurons

Jagjit S. Gill, Anthony John Windebank

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Suramin is an experimental antineoplastic agent that is currently being tested in clinical trials for a number of human cancers. In previous clinical trials, it has been noted that a significant percentage of patients treated with suramin develop a peripheral neuropathy. Both the cytotoxic (chemotherapeutic) and neurotoxic mechanisms of action of this compound are unknown. Evidence presented in this study suggests that both effects may be due to extensive disruption in glycolipid transport and/or metabolism. Suramin treated dorsal root ganglion cultures revealed an accumulation of the GM1 ganglioside and ceramide. Exposure of cultures to suramin, a cell permeable ceramide analog, or sphingomyelinase lead to apoptotic cell death demonstrated by electron microscopy, bis-benzimide staining and DNA laddering on gel electrophoresis. Furthermore, a significant increase in intracellular ceramide preceded cell death in suramin treated neurons. We propose that suramin induced ceramide accumulation within neurons leads to apoptotic cell death.

Original languageEnglish (US)
Pages (from-to)876-883
Number of pages8
JournalCell Death and Differentiation
Volume5
Issue number10
StatePublished - Oct 1998

Fingerprint

Suramin
Ceramides
Spinal Ganglia
Cell Death
Neurons
Clinical Trials
G(M1) Ganglioside
Sphingomyelin Phosphodiesterase
Glycolipids
Peripheral Nervous System Diseases
Antineoplastic Agents
Electrophoresis
Electron Microscopy
Gels
Staining and Labeling
DNA
Neoplasms

Keywords

  • Apoptosis
  • Ceramide
  • Chemotherapy
  • Dorsal root ganglion
  • Peripheral neuropathy

ASJC Scopus subject areas

  • Cell Biology

Cite this

Suramin induced ceramide accumulation leads to apoptotic cell death in dorsal root ganglion neurons. / Gill, Jagjit S.; Windebank, Anthony John.

In: Cell Death and Differentiation, Vol. 5, No. 10, 10.1998, p. 876-883.

Research output: Contribution to journalArticle

@article{b990a0f69bce48bda593dde333199d09,
title = "Suramin induced ceramide accumulation leads to apoptotic cell death in dorsal root ganglion neurons",
abstract = "Suramin is an experimental antineoplastic agent that is currently being tested in clinical trials for a number of human cancers. In previous clinical trials, it has been noted that a significant percentage of patients treated with suramin develop a peripheral neuropathy. Both the cytotoxic (chemotherapeutic) and neurotoxic mechanisms of action of this compound are unknown. Evidence presented in this study suggests that both effects may be due to extensive disruption in glycolipid transport and/or metabolism. Suramin treated dorsal root ganglion cultures revealed an accumulation of the GM1 ganglioside and ceramide. Exposure of cultures to suramin, a cell permeable ceramide analog, or sphingomyelinase lead to apoptotic cell death demonstrated by electron microscopy, bis-benzimide staining and DNA laddering on gel electrophoresis. Furthermore, a significant increase in intracellular ceramide preceded cell death in suramin treated neurons. We propose that suramin induced ceramide accumulation within neurons leads to apoptotic cell death.",
keywords = "Apoptosis, Ceramide, Chemotherapy, Dorsal root ganglion, Peripheral neuropathy",
author = "Gill, {Jagjit S.} and Windebank, {Anthony John}",
year = "1998",
month = "10",
language = "English (US)",
volume = "5",
pages = "876--883",
journal = "Cell Death and Differentiation",
issn = "1350-9047",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Suramin induced ceramide accumulation leads to apoptotic cell death in dorsal root ganglion neurons

AU - Gill, Jagjit S.

AU - Windebank, Anthony John

PY - 1998/10

Y1 - 1998/10

N2 - Suramin is an experimental antineoplastic agent that is currently being tested in clinical trials for a number of human cancers. In previous clinical trials, it has been noted that a significant percentage of patients treated with suramin develop a peripheral neuropathy. Both the cytotoxic (chemotherapeutic) and neurotoxic mechanisms of action of this compound are unknown. Evidence presented in this study suggests that both effects may be due to extensive disruption in glycolipid transport and/or metabolism. Suramin treated dorsal root ganglion cultures revealed an accumulation of the GM1 ganglioside and ceramide. Exposure of cultures to suramin, a cell permeable ceramide analog, or sphingomyelinase lead to apoptotic cell death demonstrated by electron microscopy, bis-benzimide staining and DNA laddering on gel electrophoresis. Furthermore, a significant increase in intracellular ceramide preceded cell death in suramin treated neurons. We propose that suramin induced ceramide accumulation within neurons leads to apoptotic cell death.

AB - Suramin is an experimental antineoplastic agent that is currently being tested in clinical trials for a number of human cancers. In previous clinical trials, it has been noted that a significant percentage of patients treated with suramin develop a peripheral neuropathy. Both the cytotoxic (chemotherapeutic) and neurotoxic mechanisms of action of this compound are unknown. Evidence presented in this study suggests that both effects may be due to extensive disruption in glycolipid transport and/or metabolism. Suramin treated dorsal root ganglion cultures revealed an accumulation of the GM1 ganglioside and ceramide. Exposure of cultures to suramin, a cell permeable ceramide analog, or sphingomyelinase lead to apoptotic cell death demonstrated by electron microscopy, bis-benzimide staining and DNA laddering on gel electrophoresis. Furthermore, a significant increase in intracellular ceramide preceded cell death in suramin treated neurons. We propose that suramin induced ceramide accumulation within neurons leads to apoptotic cell death.

KW - Apoptosis

KW - Ceramide

KW - Chemotherapy

KW - Dorsal root ganglion

KW - Peripheral neuropathy

UR - http://www.scopus.com/inward/record.url?scp=0031788607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031788607&partnerID=8YFLogxK

M3 - Article

C2 - 10203686

AN - SCOPUS:0031788607

VL - 5

SP - 876

EP - 883

JO - Cell Death and Differentiation

JF - Cell Death and Differentiation

SN - 1350-9047

IS - 10

ER -